-+ 0.00%
-+ 0.00%
-+ 0.00%

KYMERA THERAPEUTICS SHARES GAIN 32% PREMARKET AFTER POSITIVE DATA FOR ITS ECZEMA DRUG

Reuters·12/08/2025 13:10:23

Please log in to view news